The Pro-115 → Gln mutation in peroxisome-proliferator-activated receptor (PPAR) γ2 is extremely rare in a large cohort of U.S. Caucasians

TERRETT, Jonathan; CHAMBERLAIN, John; RASTAN, Sohaila; MARSHALL, Richard; MCGINNIS, Ralph; SPURR, Nigel; O'BRIEN, Eamonn; EVANS, Catherine; RUT, Andrew

doi:10.1042/cs0990089

Jonathan TERRETT;

Jonathan TERRETT

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

John CHAMBERLAIN;

John CHAMBERLAIN

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

†Rayne Institute, Bone and Mineral Centre, Department of Medicine, Royal Free and University College Medical School, London WC1E 6JJ, U.K.

Correspondence: Dr J. C. Chamberlain, Roche Products Ltd., 40 Broadwater Road, Welwyn Garden City, Herts., U.K. (e-mail chris.chamberlain@roche.com).

Search for other works by this author on:

This Site

PubMed

Google Scholar

Sohaila RASTAN;

Sohaila RASTAN

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Richard MARSHALL;

Richard MARSHALL

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Ralph MCGINNIS;

Ralph MCGINNIS

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Nigel SPURR;

Nigel SPURR

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Eamonn O'BRIEN;

Eamonn O'BRIEN

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Catherine EVANS;

Catherine EVANS

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Andrew RUT

*Biotechnology and Genetics, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (2000) 99 (1): 89–90.

https://doi.org/10.1042/cs0990089

This content is only available as a PDF.

2000

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

The Pro-115 → Gln mutation in peroxisome-proliferator-activated receptor (PPAR) γ2 is extremely rare in a large cohort of U.S. Caucasians

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

Cover Image

The Pro-115 → Gln mutation in peroxisome-proliferator-activated receptor (PPAR) γ2 is extremely rare in a large cohort of U.S. Caucasians

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only